Keli L. Hill

Array ( [id] => 6745864 [patent_doc_number] => 20030023047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Aglyco products and methods of use' [patent_app_type] => new [patent_app_number] => 09/817144 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13582 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023047.pdf [firstpage_image] =>[orig_patent_app_number] => 09817144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451486 [patent_doc_number] => 20020177614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Methods for treating nuerodegenerative diseases including alzheimer\'s' [patent_app_type] => new [patent_app_number] => 09/816289 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4814 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177614.pdf [firstpage_image] =>[orig_patent_app_number] => 09816289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906371 [patent_doc_number] => 20050101766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Method of identifying modulators of presenilin' [patent_app_type] => utility [patent_app_number] => 10/221291 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10958 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101766.pdf [firstpage_image] =>[orig_patent_app_number] => 10221291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882650 [patent_doc_number] => 20010049122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Phosphatidyl serine receptors and uses thereof' [patent_app_type] => new [patent_app_number] => 09/802213 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36667 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049122.pdf [firstpage_image] =>[orig_patent_app_number] => 09802213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869481 [patent_doc_number] => 20030082170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Protein from brucella species' [patent_app_type] => new [patent_app_number] => 09/785689 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2323 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082170.pdf [firstpage_image] =>[orig_patent_app_number] => 09785689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095726 [patent_doc_number] => 20020052001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Assay' [patent_app_type] => new [patent_app_number] => 09/788133 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6911 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052001.pdf [firstpage_image] =>[orig_patent_app_number] => 09788133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335199 [patent_doc_number] => 06593109 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Recombinant bone morphogenetic protein heterodimers, compositions and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/780601 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 14 [patent_no_of_words] => 29750 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593109.pdf [firstpage_image] =>[orig_patent_app_number] => 09780601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 768888 [patent_doc_number] => 07005295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-28 [patent_title] => 'β-amyloid peptide-binding proteins and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 09/774936 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15226 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/005/07005295.pdf [firstpage_image] =>[orig_patent_app_number] => 09774936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289201 [patent_doc_number] => 20020054874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Antibodies that mimic actions of neurotrophins' [patent_app_type] => new [patent_app_number] => 09/770949 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16657 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054874.pdf [firstpage_image] =>[orig_patent_app_number] => 09770949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874445 [patent_doc_number] => 20030194742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'DIAGNOSIS OF TAUOPATHIES' [patent_app_type] => new [patent_app_number] => 09/769180 [patent_app_country] => US [patent_app_date] => 2001-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194742.pdf [firstpage_image] =>[orig_patent_app_number] => 09769180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818218 [patent_doc_number] => 20030069176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods for treating neurological injuries and disorders' [patent_app_type] => new [patent_app_number] => 09/756481 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8655 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069176.pdf [firstpage_image] =>[orig_patent_app_number] => 09756481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278424 [patent_doc_number] => 20020107186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Novel polypeptides and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 09/755665 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 45473 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107186.pdf [firstpage_image] =>[orig_patent_app_number] => 09755665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6900092 [patent_doc_number] => 20010009768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-26 [patent_title] => 'Polynucleotides encoding cytokine designated LERK-5' [patent_app_type] => new [patent_app_number] => 09/754105 [patent_app_country] => US [patent_app_date] => 2001-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20010009768.pdf [firstpage_image] =>[orig_patent_app_number] => 09754105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082146 [patent_doc_number] => 20020082190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/740041 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 23780 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082190.pdf [firstpage_image] =>[orig_patent_app_number] => 09740041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298867 [patent_doc_number] => 06627739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => '-secretase enzyme compositions and methods' [patent_app_type] => B1 [patent_app_number] => 09/724566 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 57 [patent_no_of_words] => 42715 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627739.pdf [firstpage_image] =>[orig_patent_app_number] => 09724566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264060 [patent_doc_number] => 06660483 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Diagnostic marker for neurological conditions' [patent_app_type] => B1 [patent_app_number] => 09/688078 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25177 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660483.pdf [firstpage_image] =>[orig_patent_app_number] => 09688078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325018 [patent_doc_number] => 06602851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'SMDF and GGF neuregulin splice variant isoforms and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/684708 [patent_app_country] => US [patent_app_date] => 2000-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 24647 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602851.pdf [firstpage_image] =>[orig_patent_app_number] => 09684708 [rel_patent_id] =>[rel_patent_doc_number] =>)